Exasol (EXL) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
19 Aug, 2026Executive summary
H1 2026 saw mixed results: recurring revenue grew slightly and churn dropped from 24% to 10%, but total revenue and ARR declined due to weak upsell, postponed expansion investments, and delayed partner collaboration.
Eleven new customers were acquired, mainly in focus verticals and driven by data sovereignty and agentic AI, but expansion with existing clients lagged.
Net income for H1 2026 was EUR 1.2 million, nearly flat year-over-year.
Financial highlights
Revenue for H1 2026 was EUR 19.0 million, down from EUR 21.5 million in H1 2025, mainly due to the absence of last year’s one-time hardware deal.
Recurring revenue increased to EUR 18.9 million from EUR 18.6 million.
EBITDA was EUR 1.6 million, down from EUR 2.0 million in H1 2025.
Net liquid funds improved to EUR 21.6 million as of June 30, 2026.
Outlook and guidance
ARR for FY 2026 is expected to change between -2% and +2%, with revenue projected to decline in the upper single-digit percentage range.
EBITDA guidance narrowed to EUR 3.0–3.5 million.
Upsell recovery and partner collaboration benefits are anticipated only next year.
Latest events from Exasol
- ARR decline slowed, churn improved, and 2026 guidance for growth and EBITDA was confirmed.EXL
Q1 2026 TU - 2025 saw robust growth, AI integration, and improved profitability, with ARR set to rise in 2026.EXL
Q4 2025 - EBITDA and net income surged, with focus industries driving ARR growth despite overall ARR decline.EXL
Q4 2025 TU - Revenue and EBITDA up, ARR down 4.1%; focus verticals and MariaDB to drive 2026 growth.EXL
Q3 2025 TU - Revenue up 10.8%, profitability rose, and focus verticals now drive 69% of ARR.EXL
Q2 2025 - Positive EBITDA and double-digit growth achieved, with focus on regulated, hybrid markets.EXL
Q3 2024 TU - Profitable H1 2024 with 12% ARR growth, 9% revenue growth, and strong liquidity.EXL
H1 2024 - Q1 2025 revenue up 25%, profitability surged, focus verticals offset ARR decline.EXL
Q1 2025 TU - First-ever positive EBITDA and net income, with strong sector growth and robust 2025 outlook.EXL
Q4 2024 TU